ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 251 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,324,000 | -27.4% | 17,701 | -38.9% | 0.31% | -22.1% |
| Q2 2020 | $1,824,000 | +22.7% | 28,971 | +14.3% | 0.40% | +10.7% |
| Q2 2019 | $1,487,000 | +106.5% | 25,356 | +53.6% | 0.36% | +219.3% |
| Q2 2018 | $720,000 | -58.7% | 16,509 | -62.6% | 0.11% | -60.7% |
| Q1 2018 | $1,742,000 | +16.1% | 44,112 | -0.1% | 0.29% | +7.8% |
| Q4 2017 | $1,501,000 | -37.7% | 44,176 | -53.2% | 0.27% | -15.9% |
| Q3 2017 | $2,408,000 | – | 94,435 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 252,500 | $11,320,000 | 4.95% |
| Rubric Capital Management LP | 857,103 | $38,424,000 | 3.59% |
| PFM Health Sciences, LP | 3,255,230 | $145,932,000 | 3.22% |
| Partner Investment Management, L.P. | 40,605 | $1,820,000 | 2.10% |
| DAFNA Capital Management LLC | 93,942 | $4,211,000 | 1.82% |
| Atika Capital Management LLC | 195,000 | $8,742,000 | 1.78% |
| Perceptive Advisors | 1,400,171 | $62,770,000 | 1.77% |
| EMORY UNIVERSITY | 47,779 | $2,142,000 | 1.51% |
| Rhenman & Partners Asset Management AB | 234,558 | $10,515,000 | 1.23% |
| Eversept Partners, LP | 75,721 | $3,394,572 | 0.99% |